[Featured Stock] Kwangdong Pharmaceutical Surges as a Key Povidone Iodine-Related Stock... "Suppressing COVID-19"
[Asia Economy Reporter Hyunseok Yoo] Kwangdong Pharmaceutical is showing strong performance. Reports that povidone-iodine solution, mainly used for disinfection, has an inhibitory effect on the novel coronavirus infection (COVID-19) appear to have influenced this.
On the 29th at 9:45 AM, Kwangdong Pharmaceutical was traded at 10,850 KRW, up 17.30% (1,600 KRW) compared to the previous trading day.
It is known that in 2018, Kwangdong Pharmaceutical signed an agreement with Korea Mundipharma to jointly sell over 40 types of over-the-counter drugs and quasi-drugs including Betadine. The active ingredient of Betadine throat spray contains povidone-iodine.
According to a study by the University of Connecticut in the United States, povidone-iodine spray administered into the nose was found to rapidly inhibit the COVID-19 virus, SBS reported.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- US Demands Transfer of 400kg Enriched Uranium... Iran Insists on Recognition of Hormuz Rights
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
In the study, povidone solutions of varying concentrations were sprayed onto petri dishes cultured with the COVID-19 virus and compared with 70% alcohol spray. Even at a low concentration of 0.5%, exposure for 15 seconds showed a greater inhibitory effect than 70% alcohol.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
